Announcements Trials
Browse Landscape

Phase

Phase 2 39Phase 1 11Phase 3 10Phase 4 6Phase 1/2 6Phase NA 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Ovarian Neoplasms 2Breast Neoplasms 2Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma 1Carcinoma, Ovarian Epithelial 1

Interventions

Exercise 112Surveys and Questionnaires 55Early Intervention, Educational 49Standard of Care 46Methods 46Magnetic Resonance Spectroscopy 45Blood Specimen Collection 44Acupuncture Therapy 44Educational Status 43Radiotherapy 36Mammography 36Control Groups 31Therapeutics 29Counseling 29Psychiatric Rehabilitation 27Cyclophosphamide 27Sentinel Lymph Node Biopsy 25Biopsy 24Yoga 20Mastectomy, Segmental 20Resistance Training 19Palliative Care 18Neoadjuvant Therapy 18High-Energy Shock Waves 18Doxorubicin 18Cognitive Behavioral Therapy 18Magnetic Resonance Imaging 17Practice Guidelines as Topic 16Paclitaxel 16Trastuzumab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms × liposomal doxorubicin × Clear all
NCT05656079 2022-12-19

easy laugh

Shanghai Pudong Hospital

Phase NA Unknown
204 enrolled
Breast

Breast Neoplasms

NCT03221881 2017-07-19

Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer

Hebei Medical University Fourth Hospital

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡